Hing C. Wong - 19 Jul 2021 Form 3 Insider Report for HCW Biologics Inc. (HCWB)

Role
Chief Executive Officer, Director
Signature
/s/ Hing C. Wong
Issuer symbol
HCWB
Transactions as of
19 Jul 2021
Net transactions value
$0
Form type
3
Filing time
19 Jul 2021, 16:52:37 UTC
Next filing
23 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding HCWB Common Stock 4,285,714 19 Jul 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HCWB Series A Redeemable Preferred Stock 19 Jul 2021 Common Stock 6,316,691 Direct F1, F2
holding HCWB Series B Redeemable Preferred Stock 19 Jul 2021 Common Stock 2,954,285 Direct F3, F4
holding HCWB Series C Redeemable Preferred Stock 19 Jul 2021 Common Stock 1,071,428 Direct F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Series A Redeemable Preferred Stock is convertible into the issuer's common stock on a one-for-one basis and has no expiration date. It will automatically convert into common stock upon the closing of the issuer's initial public offering.
F2 Includes 902,977 shares purchased jointly by Hing C. Wong and Bee Yau Huang.
F3 The Series B Redeemable Preferred Stock is convertible into the issuer's common stock on a one-for-one basis and has no expiration date. It will automatically convert into common stock upon the closing of the issuer's initial public offering.
F4 Includes 1,525,714 shares purchased jointly by Hing C. Wong and Bee Yau Huang.
F5 The Series C Redeemable Preferred Stock is convertible into the issuer's common stock on a one-for-one basis and has no expiration date. It will automatically convert into common stock upon the closing of the issuer's initial public offering.
F6 Represents shares purchased jointly by Hing C. Wong and Bee Yau Huang.

Remarks:

Exhibit 24.1: Power of Attorney